Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro

Due to the presence of the renin-angiotensin system (RAS) in tissues and its specific influence on white adipose tissue, fat cells are possible targets of pharmacological RAS blockers commonly used as anti-hypertensive drugs. In the present study, we investigated the effects of different RAS blocker...

Full description

Bibliographic Details
Main Authors: R de O. Caminhotto, R.A.L. Sertié, S. Andreotti, A.B. Campaãa, F.B. Lima
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2016-07-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000800608&lng=en&tlng=en
_version_ 1818154654093017088
author R de O. Caminhotto
R.A.L. Sertié
S. Andreotti
A.B. Campaãa
F.B. Lima
author_facet R de O. Caminhotto
R.A.L. Sertié
S. Andreotti
A.B. Campaãa
F.B. Lima
author_sort R de O. Caminhotto
collection DOAJ
description Due to the presence of the renin-angiotensin system (RAS) in tissues and its specific influence on white adipose tissue, fat cells are possible targets of pharmacological RAS blockers commonly used as anti-hypertensive drugs. In the present study, we investigated the effects of different RAS blockers on fat cell metabolism, more specifically on lipolysis, lipogenesis and oxidation of energy substrates. Isolated primary adipocytes were incubated with different RAS blockers (aliskiren, captopril and losartan) in vitro for 24 h and lipolysis, lipogenesis and glucose oxidation capacities were determined in dose-response assays to a β-adrenergic agonist and to insulin. Although no change was found in lipolytic capacity, the RAS blockers modulated lipogenesis and glucose oxidation in a different way. While captopril decreased insulin-stimulated lipogenesis (−19% of maximal response and −60% of insulin responsiveness) due to reduced glucose derived glycerol synthesis (−19% of maximal response and 64% of insulin responsiveness), aliskiren increased insulin-stimulated glucose oxidation (+49% of maximal response and +292% of insulin responsiveness) in fat cells. Our experiments demonstrate that RAS blockers can differentially induce metabolic alterations in adipocyte metabolism, characterized by a reduction in lipogenic responsiveness or an increase in glucose oxidation. The impact of RAS blockers on adipocyte metabolism may have beneficial implications on metabolic disorders during their therapeutic use in hypertensive patients.
first_indexed 2024-12-11T14:29:56Z
format Article
id doaj.art-f291f4d735ba48b3ba5eef69815ddfde
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-12-11T14:29:56Z
publishDate 2016-07-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-f291f4d735ba48b3ba5eef69815ddfde2022-12-22T01:02:29ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2016-07-0149810.1590/1414-431x20165409S0100-879X2016000800608Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitroR de O. CaminhottoR.A.L. SertiéS. AndreottiA.B. CampaãaF.B. LimaDue to the presence of the renin-angiotensin system (RAS) in tissues and its specific influence on white adipose tissue, fat cells are possible targets of pharmacological RAS blockers commonly used as anti-hypertensive drugs. In the present study, we investigated the effects of different RAS blockers on fat cell metabolism, more specifically on lipolysis, lipogenesis and oxidation of energy substrates. Isolated primary adipocytes were incubated with different RAS blockers (aliskiren, captopril and losartan) in vitro for 24 h and lipolysis, lipogenesis and glucose oxidation capacities were determined in dose-response assays to a β-adrenergic agonist and to insulin. Although no change was found in lipolytic capacity, the RAS blockers modulated lipogenesis and glucose oxidation in a different way. While captopril decreased insulin-stimulated lipogenesis (−19% of maximal response and −60% of insulin responsiveness) due to reduced glucose derived glycerol synthesis (−19% of maximal response and 64% of insulin responsiveness), aliskiren increased insulin-stimulated glucose oxidation (+49% of maximal response and +292% of insulin responsiveness) in fat cells. Our experiments demonstrate that RAS blockers can differentially induce metabolic alterations in adipocyte metabolism, characterized by a reduction in lipogenic responsiveness or an increase in glucose oxidation. The impact of RAS blockers on adipocyte metabolism may have beneficial implications on metabolic disorders during their therapeutic use in hypertensive patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000800608&lng=en&tlng=enAdipocytesLipolysisLipogenesisGlucoseRenin-angiotensin system
spellingShingle R de O. Caminhotto
R.A.L. Sertié
S. Andreotti
A.B. Campaãa
F.B. Lima
Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
Brazilian Journal of Medical and Biological Research
Adipocytes
Lipolysis
Lipogenesis
Glucose
Renin-angiotensin system
title Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
title_full Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
title_fullStr Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
title_full_unstemmed Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
title_short Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
title_sort renin angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
topic Adipocytes
Lipolysis
Lipogenesis
Glucose
Renin-angiotensin system
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000800608&lng=en&tlng=en
work_keys_str_mv AT rdeocaminhotto reninangiotensinsystemblockersregulatethemetabolismofisolatedfatcellsinvitro
AT ralsertie reninangiotensinsystemblockersregulatethemetabolismofisolatedfatcellsinvitro
AT sandreotti reninangiotensinsystemblockersregulatethemetabolismofisolatedfatcellsinvitro
AT abcampaaa reninangiotensinsystemblockersregulatethemetabolismofisolatedfatcellsinvitro
AT fblima reninangiotensinsystemblockersregulatethemetabolismofisolatedfatcellsinvitro